Skip to main content

Advertisement

Log in

Our Experience of OSAKA Regimen (Bladder Preservation) in Patients with Advanced Bladder Cancer

  • Original Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Introduction and Objectives

OSAKA regimen is a novel bladder preservation therapy involving balloon-occluded selective arterial infusion of radio-sensitizing chemotherapeutic agent with concurrent hemodialysis (HD), followed by radiation therapy. Objectives are to study the feasibility of this novel regimen in patients with advanced cancer bladder (Ca Bladder).

Methods

Two patients having advanced Ca Bladder with cisplatin ineligibility and poor performance status were managed with OSAKA regimen. Patients undergo super selective catheterisation of the anterior division of the internal iliac artery, followed by concurrent instillation of cisplatin (100 mg) via microcatheters and hemodialysis. Within 72 h, definitive radiation therapy is given. Image-guided radiation therapy (IGRT) with Helical Tomo using an Accuracy Radixact Tomography machine was used. 60 Gray/30 fractions is given to the bladder and nodes (50 Gray to bladder and nodes plus margin, with a boost of 10 Gray to bladder plus margin). Response is monitored by 3 monthly fluorodeoxyglucose positron emission tomography (FDG PET) imaging.

Results

Our first patient tolerated the procedure well and showed a complete response at 3 months of FDG PET imaging, but unfortunately, 1 year of FDG PET showed bony metastases, and the patient was managed accordingly. Our second patient also tolerated the regimen well, showed a complete response at 3 and 12 months of FDG PET imaging, and is under follow-up.

Conclusions

The OSAKA regimen, as a bladder preservation strategy, is feasible and safe in selective advanced Ca Bladder patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Payton S (2010) ‘OMC’ regimen shows curative potential in selected patients. Nat Rev Urol 7:61. https://doi.org/10.1038/nrurol.2009.259

    Article  Google Scholar 

  2. Azuma H, Yamamoto K, Inamoto T, Ibuki N, Kotake Y, Sakamoto T, Kiyama S, Ubai T, Takahara K, Segawa N, Narumi Y, Katsuoka Y (2009) Total cystectomy versus bladder preservation therapy for locally invasive bladder cancer: effect of combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation. Am J Clin Oncol 2009 32(6):592–606. https://doi.org/10.1097/COC.0b013e318199fb42

    Article  CAS  PubMed  Google Scholar 

  3. Azuma H, Inamoto T, Takahara K, Nomi H, Hirano H, Ibuki N, Uehara H, Komura K, Minami K, Uchimoto T, Saito K, Takai T, Tanda N, 和宏, 山本 & Narumi, Yoshihumi & Kiyama, Satoshi (2015) Novel bladder preservation therapy with Osaka Medical College regimen. J Urol 193. https://doi.org/10.1016/j.juro.2014.08.094

Download references

Acknowledgements

We would like to express our sincere gratitude to all the individuals that have contributed to the publication of this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Manav Gideon.

Ethics declarations

Ethical Approval

Ethical clearance for the study has been obtained from the Ethical committee of our institution.

Consent to Participate

Written informed consent for publication of their clinical details and/or clinical images was obtained from the patient/parent/guardian/ relative of the patient. A copy of the consent form is available for review by the Editor of this journal.

Conflict of Interest

The authors declare no competing interests.

Patient Consent Form

Yes.

Guarantor

Not applicable.

Level of Evidence

3 (Expert opinions).

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Awards

We won the USICON 2023 BEST POSTER PRIZE AWARD for this case series titled “Our experience of OSAKA regimen in patients with advanced bladder cancer.”

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ginil Kumar, P., Gideon, M., Ravi Chandran, K. et al. Our Experience of OSAKA Regimen (Bladder Preservation) in Patients with Advanced Bladder Cancer. Indian J Surg Oncol 15, 264–267 (2024). https://doi.org/10.1007/s13193-024-01879-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-024-01879-0

Keywords

Navigation